Cargando…

Comparison of the clinical characteristics and comprehensive assessments of the 2011 and 2017 GOLD classifications for patients with COPD in China

OBJECTIVE: Compared with the 2011 Global Initiative for Chronic Obstructive Lung Disease (GOLD), there have been significant changes in the 2017 GOLD classification. The purpose of this study was to analyze the changes in clinical characteristics of the new A-B-C-D system and to explore its role in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hu, Yu-He, Liang, Zhen-Yu, Xu, Li-Mei, Xu, Wen-Hui, Liao, Hao, Li, Rui, Wang, Kai, Xu, Ying, Ou, Chun-Quan, Chen, Xin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove Medical Press 2018
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6167996/ https://www.ncbi.nlm.nih.gov/pubmed/30319249 http://dx.doi.org/10.2147/COPD.S174668

Ejemplares similares

Prevalence and prognostic ability of the GOLD 2017 classification compared to the GOLD 2011 classification in a Norwegian COPD cohort
por: Le, Lan Ai Kieu, et al.
Publicado: (2019)

2011 GOLD Stages of COPD: Transitions, Predictor Factors and Comparison with 2017 GOLD Stages
por: Bernabeu-Mora, Roberto, et al.
Publicado: (2020)

Clinical characteristics and outcomes in Japanese patients with COPD according to the 2017 GOLD classification: the Ishinomaki COPD Network Registry
por: Kobayashi, Seiichi, et al.
Publicado: (2018)

Serum C-reactive protein level in COPD patients stratified according to GOLD 2011 grading classification
por: Lin, Yi-Hua, et al.
Publicado: (2016)

Real-Life GOLD 2011 Implementation: The Management of COPD Lacks Correct Classification and Adequate Treatment
por: Koblizek, Vladimir, et al.
Publicado: (2014)

Impact of changing GOLD guidelines (2007–2011–2017) on assignment of a COPD patient to disease severity category
por: Nowak, Marcin, et al.
Publicado: (2018)

Classification of COPD patients and compliance to recommended treatment in Greece according to GOLD 2017 report: the RELICO study
por: Tzanakis, Nikolaos, et al.
Publicado: (2021)

Validation of the GOLD 2017 and new 16 subgroups (1A–4D) classifications in predicting exacerbation and mortality in COPD patients
por: Han, Meng-Zhi, et al.
Publicado: (2018)

Prognostic utility of the 2011 GOLD classification and other multidimensional tools in Asian COPD patients: a prospective cohort study
por: Chan, Hiang Ping, et al.
Publicado: (2016)

Clinical impacts of the classification by 2017 GOLD guideline comparing previous ones on outcomes of COPD in real-world cohorts
por: Song, Jin Hwa, et al.
Publicado: (2018)

Characteristics of 2017 GOLD COPD group A: a multicenter cross-sectional CAP study in Japan
por: Oishi, Keiji, et al.
Publicado: (2018)

Characteristics of COPD patients according to GOLD classification and clinical phenotypes in the Russian Federation: the SUPPORT trial
por: Arkhipov, Vladimir, et al.
Publicado: (2017)

Changes in definition lead to changes in the clinical characteristics across COPD categories according to GOLD 2017: a national cross-sectional survey in China
por: Sun, Lina, et al.
Publicado: (2017)

Adherence to the GOLD Guideline in COPD Management of South Korea: Findings from KOCOSS Study 2011–2018
por: Kim, Tae-Ok, et al.
Publicado: (2019)

The Characteristics of Airflow Limitation and Future Exacerbations in Different GOLD Groups of COPD Patients
por: Song, Qing, et al.
Publicado: (2021)

Adequate Patient Characterization in COPD: Reasons to Go Beyond GOLD Classification
por: Verhage, Tewe L, et al.
Publicado: (2009)

Healthcare, Medication Utilization and Outcomes of Patients with COPD by GOLD Classification in England
por: Sansbury, Leah B, et al.
Publicado: (2021)

The Evaluation of Interstitial Abnormalities in Group B of the 2011 Global Initiative for Chronic Obstructive Lung Disease (GOLD) Classification of Chronic Obstructive Pulmonary Disease (COPD)
por: Ohgiya, Masahiro, et al.
Publicado: (2017)

Everyday clinical practice and its relationship to 2010 and 2011 GOLD guideline recommendations for the management of COPD
por: Papala, Maria, et al.
Publicado: (2013)

Respiratory parameters predict poor outcome in COPD patients, category GOLD 2017 B
por: Brat, Kristian, et al.
Publicado: (2018)

The impact of 2011 and 2017 Global Initiative for Chronic Obstructive Pulmonary Disease (GOLD) guidelines on allocation and pharmacological management of patients with COPD in Taiwan: Taiwan Obstructive Lung Disease (TOLD) study
por: Hsieh, Meng-Jer, et al.
Publicado: (2018)

Does the GOLD 2017 Classification Improve the Ability to Predict Exacerbation and Mortality?
por: Hwang, Hun-Gyu
Publicado: (2018)

Impact of using the new GOLD classification on the distribution of COPD severity in clinical practice
por: Hernández, Marcos, et al.
Publicado: (2018)

A shadow in the GOLD ABCD classification system: measurement of perception of symptoms in COPD
por: Crisafulli, Ernesto, et al.
Publicado: (2021)

GOLD Classifications, COPD Hospitalization, and All-Cause Mortality in Chronic Obstructive Pulmonary Disease: The HUNT Study
por: Bhatta, Laxmi, et al.
Publicado: (2020)

Cycle ergometer and inspiratory muscle training offer modest benefit compared with cycle ergometer alone: a comprehensive assessment in stable COPD patients
por: Wang, Kai, et al.
Publicado: (2017)

From GOLD 0 to Pre-COPD
por: Han, MeiLan K., et al.
Publicado: (2021)

Characteristics and risk factors for inconsistency between the risk of exacerbations and the severity of airflow limitation in COPD based on GOLD 2017: A retrospective, cross-sectional study
por: Huang, Wei-Chang, et al.
Publicado: (2018)

Spatial inequality, characteristics of internal migration, and pulmonary tuberculosis in China, 2011–2017: a spatial analysis
por: He, Wen-Chong, et al.
Publicado: (2020)

The epidemiological characteristics and spatio-temporal analysis of childhood hand, foot and mouth disease in Korea, 2011-2017
por: Baek, Soojin, et al.
Publicado: (2020)

Validity of the GOLD 2017 classification in the prediction of mortality and respiratory hospitalization in patients with chronic obstructive pulmonary disease
por: Lee, Seung Jun, et al.
Publicado: (2019)

Clinical characteristics of patients with chronic obstructive pulmonary disease assessed using GOLD 2016 and GOLD 2018 classifications: a cross-sectional study in China
por: Jian, Wenhua, et al.
Publicado: (2021)

Clinicopathological characteristics and prognostic analysis of Lauren classification in gastric adenocarcinoma in China
por: Qiu, Miao-zhen, et al.
Publicado: (2013)

A study to assess COPD Symptom-based Management and to Optimise treatment Strategy in Japan (COSMOS-J) based on GOLD 2011
por: Betsuyaku, Tomoko, et al.
Publicado: (2013)

Molecular characterization of measles viruses in China: Circulation dynamics of the endemic H1 genotype from 2011 to 2017
por: Wang, Huiling, et al.
Publicado: (2019)

COPD Surveillance—United States, 1999-2011
por: Ford, Earl S., et al.
Publicado: (2013)

Clonality of Fluconazole-Nonsusceptible Candida tropicalis in Bloodstream Infections, Taiwan, 2011–2017
por: Chen, Pao-Yu, et al.
Publicado: (2019)

Epidemiological and Virological Characteristics of Influenza in Chongqing, China, 2011-2015
por: Qi, Li, et al.
Publicado: (2016)

Spatial clustering of suicide mortality and associated community characteristics in Kanagawa prefecture, Japan, 2011–2017
por: Yamaoka, Kazue, et al.
Publicado: (2020)

Epidemiological and aetiological characteristics of hand, foot, and mouth disease in Sichuan Province, China, 2011–2017
por: Peng, Di, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_7cingj02j7efk7qhjesg1hnir8